01 1Curia
01 1HYDROCORTISONE HEMISUCCINATE MICRONIZED AND NON-MICRONIZED
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-10-30
Pay. Date : 2023-09-20
DMF Number : 38832
Submission : 2023-09-18
Status : Active
Type : II
20
Curia Spain Sau, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is HYDROCORTISONE HEMISUCCINATE MICRONIZED AND NON-MICRONIZED, with a corresponding US DMF Number 38832.
Remarkably, this DMF maintains an Active status since its submission on September 18, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 30, 2023, and payment made on September 20, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
